位置:成果数据库 > 期刊 > 期刊详情页
RNA干扰与肿瘤基因治疗
  • 期刊名称:生命的化学,2009,29 (3):318-22
  • 时间:0
  • 分类:R730[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]陕西师范大学生命科学学院基因治疗研究室,西安710062
  • 相关基金:国家科技部863课题(2006AA022163):陕西省自然科学基金项目(2007C201);国家自然科学基金项目(30872993)资助
  • 相关项目:新型靶向条件复制型溶瘤腺病毒载体Ad5/11 D24在恶性脑胶质母细胞瘤中的实验治疗研究
中文摘要:

RNA干扰(RNA interference,RNAi)是一种由外源性或内源性双链RNA分子阻断或者降低同源基因表达的现象。由于RNAi对靶基因的沉默作用具有高效性、特异性等特点,近年来已广泛应用于基因治疗。肿瘤除早期进行手术及化疗等传统治疗手段外,目前尚无有效的治疗对策。采用RNAi技术的基因治疗手段为肿瘤的有效治疗带来了新的希望。本文将对RNAi干扰机制、RNAi在肿瘤基因治疗中的研究进展及其在应用过程中所面临的挑战作一综述。

英文摘要:

RNA interference (RNAi) is a phenomenon that the endogenous or exogenous double stranded RNA induces the degradation of the homologous mRNA, which leads to the inhibition of specific gene expression. Due to its efficacy and specificity, RNAi has been widely used in gene therapy. There is currently no effective strategy for tumor therapy except for traditional treatment such as surgery and chemotherapy at early stage. However, gene therapy involved in RNAi technology brings new hope to effective treatment of tumor. In this paper, we reviewed the mechanisms involved in RNAi, the advancement of siRNA in tumor gene therapy and challenges faced by people in the application of RNAi.

同期刊论文项目
同项目期刊论文